c-Met Inhibitor JNJ-38877605
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Protein Kinase Inhibitor ->
Tyrosine Kinase Inhibitor -> c-Met Inhibitor JNJ-38877605
c-Met Inhibitor JNJ-38877605 Definition
An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. c-Met inhibitor JNJ-38877605 selectively inhibits c-Met (mesenchymal-epithelial transition), a receptor tyrosine kinase (RTK) involved in cancer cell survival and invasiveness, and tumor angiogenesis. c-Met is also known as hepatocyte growth factor receptor (HGFR).
c-Met Inhibitor JNJ-38877605 Synonyms
c-Met Inhibitor JNJ-38877605, JNJ-38877605
Terms in c-Met Inhibitor JNJ-38877605 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.